Toxic nodular goiter (TNG) is a thyroid disorder characterized by the formation of one or more nodules in the thyroid tissue that produce excessive amounts of thyroid hormones. This hyperthyroidism can occur either as a result of autonomous nodule growth or in combination with other thyroid disorders. TNG can be associated with a variety of symptoms, including weight loss, palpitations, sweating, and anxiety. If left untreated, the disorder can lead to serious complications, including thyroid storm. It is important to conduct proper diagnosis and treatment to prevent the progression of this condition.
History of the disease and interesting historical facts
The history of toxic nodular goiter goes back to ancient times. The first mentions of thyroid disease can be found in medical texts from ancient Egypt and Greece. In the 18th century, Swiss anatomist Albrecht von Haller first described goiter as an enlargement of the thyroid gland. In the 19th century, scientists conducted detailed studies of its function and identified cases of hyperthyroidism. Understanding the role of iodine in the formation of thyroid hormones was revealed only in the early 20th century, when iodine deficiency was discovered in the 1920s to cause goiter and other disorders. Interestingly, in the 1940s, the first treatment based on iodine and thyroid hormones was developed, which significantly improved the outcomes of patients with toxic nodular goiter.
Epidemiology
According to various epidemiological studies, toxic nodular goiter occurs in 4-7% of the population, with some variations depending on the region, age and gender. For example, women are 5-10 times more likely to develop the disease than men. Additionally, the predisposition to TNG increases in older people. The presence of thyroid nodules is observed in about 50% people over 60 years of age, but the presence of toxic nodules is much less common. According to WHO, the prevalence of the disease increases in areas with iodine deficiency and with increasing levels of environmental pollution.
Genetic predisposition to this disease
Genetic predisposition plays an important role in the development of toxic nodular goiter. Studies have shown that certain mutations and polymorphisms in genes associated with the regulation of thyroid function can increase the risk of its disease. In particular, the TSHR (thyroid-stimulating hormone receptor), thyroglobulin and PAPSS2 genes may be involved in the pathogenesis. In people with a family history of thyroid disease, the risk of developing TNG increases by 2-3 times. It is also worth mentioning that the presence of autoimmune diseases, such as Graves' disease, can interact with genetic factors, which also contributes to the development of toxic nodular goiter.
Risk factors for the development of this disease
Risk factors for the development of toxic nodular goiter can be divided into physical, chemical and others. Physical factors include:
- Deficiency of iodine, which is necessary for the synthesis of thyroid hormones;
- Age – the risk increases with increasing patient age;
- Gender – women are more susceptible to the disease;
Chemical factors:
- Exposure to various carcinogens, including radiation;
- Long-term use of certain medications, such as amiodarone;
Additional associated risk factors include a history of nodules or a family history of thyroid disease, as well as stressful situations.
Diagnosis of this disease
Diagnosis of toxic nodular goiter involves several stages. The main symptoms of the disease may include:
- Enlargement of the thyroid gland (goiter);
- Symptoms of hyperthyroidism such as sweating, anxiety, increased heart rate;
- Weight loss without any significant dieting;
Laboratory tests include TSH, T4, and T3 levels to evaluate thyroid function. Radiological examinations, including thyroid ultrasound, help determine the presence of nodules, their size, and structure. Other diagnostics may include scintigraphy, which helps evaluate the functional activity of the nodules. Differential diagnosis is necessary to exclude other thyroid diseases, such as cancer or autoimmune diseases.
Treatment
Treatment of toxic nodular goiter depends on the structure and function of the nodules, as well as the patient's condition. General treatment includes:
- Control of thyroid hormone levels;
- Normalization of metabolism;
Pharmacological treatment usually includes antithyroid drugs such as methimazole. If drug treatment is ineffective, surgery, such as thyroidectomy, may be indicated. In some cases, radioactive iodine is used to destroy functionally active nodes. Additional treatments may include the use of beta blockers to relieve cardiovascular symptoms.
List of medications used to treat this disease
Among the drugs used to treat toxic nodular goiter, the following can be distinguished:
- Methimazole;
- Propranolol (for symptomatic treatment);
- Potassium iodide (in preparation for surgical treatment);
- Radioactive iodine;
- Cabozantinib (in some cases of metastatic cancer).
Disease monitoring
Monitoring of toxic nodular goiter includes regular examinations and control of thyroid hormone levels. Ultrasound of the thyroid gland is also necessary to track changes in the nodes. The prognosis of the disease is favorable in most cases with timely diagnosis and treatment. Complications can occur in the form of a thyrotoxic crisis, especially during stress or surgery, and require emergency treatment.
Age-related features of the disease
Toxic nodular goiter can manifest itself differently depending on the patient's age. In young people, the disease can develop rapidly, with pronounced symptoms of hyperthyroidism. In older people, asymptomatic progression is more often observed, as well as more pronounced symptoms of cardiovascular failure. In addition, in older patients, the risks of surgical intervention and serious complications increase significantly.
Questions and Answers
- What is toxic nodular goiter? Toxic nodular goiter is a thyroid disorder characterized by the formation of nodules that produce excess thyroid hormones, causing hyperthyroidism.
- What are the main symptoms of toxic nodular goiter? The main symptoms include an enlarged thyroid gland, weight loss, palpitations, sweating and anxiety.
- What diagnostic methods are available to determine toxic nodular goiter? Diagnostics include laboratory tests for thyroid hormone levels, ultrasound examination and thyroid scintigraphy.
- What are the main treatments for toxic nodular goiter? The main treatments include pharmacotherapy with antithyroid drugs, surgery, and radioactive iodine.
- What is the prognosis for toxic nodular goiter? The prognosis is usually favorable with early diagnosis and adequate treatment, but serious complications such as thyrotoxic crisis may occur.
